Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |